Macquarie Group LTD Natera, Inc. Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Natera, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 250,810 shares of NTRA stock, worth $26.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

250,810

Previous 300,079 16.42%

Holding current value

$26.7 Million

Previous $18.8 Million 22.04%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$59.21 - $92.9 $2.92 Million - $4.58 Million	-49,269 Reduced 16.42%	250,810 $22.9 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $1.94 Million - $3.23 Million	51,561 Added 20.75%	300,079 $18.8 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $1.25 Million - $1.8 Million	28,729 Added 13.07%	248,518 $11 Million
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $867,260 - $1.02 Million	-18,421 Reduced 7.73%	219,789 $10.7 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $3.37 Million - $5.37 Million	92,156 Added 63.1%	238,210 $13.2 Million

Q4 2022 Feb 21, 2023	BUY	$34.17 - $47.91 $871,471 - $1.22 Million	25,504 Added 21.16%	146,054 $5.87 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $206,475 - $316,897	-5,591 Reduced 4.43%	120,550 $5.33 Million
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $200,791 - $317,926	-7,138 Reduced 5.36%	126,141 $4.47 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $398,617 - $1.2 Million	13,147 Added 10.94%	133,279 $5.42 Million
Q4 2021 Feb 11, 2022	SELL	$86.26 - $119.0 $48.4 Million - $66.8 Million	-561,158 Reduced 82.37%	120,132 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $34.4 Million - $43.3 Million	-342,979 Reduced 33.49%	681,290 $75.9 Million
Q2 2021 Aug 13, 2021	SELL	$86.05 - $119.72 $20.7 Million - $28.7 Million	-240,003 Reduced 18.98%	1,024,269 $116 Million
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $44.9 Million - $61.1 Million	-491,389 Reduced 27.99%	1,264,272 $128 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $8.92 Million - $15 Million	-133,855 Reduced 7.08%	1,755,661 $175 Million
Q3 2020 Nov 13, 2020	SELL	$45.89 - $72.67 $21.9 Million - $34.6 Million	-476,765 Reduced 20.15%	1,889,516 $136 Million
Q2 2020 Aug 11, 2020	BUY	$26.36 - $49.86 $577,784 - $1.09 Million	21,919 Added 0.93%	2,366,281 $118 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $8 Million - $18.6 Million	463,192 Added 24.62%	2,344,362 $70 Million
Q4 2019 Feb 14, 2020	SELL	$32.1 - $40.4 $4.13 Million - $5.2 Million	-128,659 Reduced 6.4%	1,881,170 $63.4 Million
Q3 2019 Nov 14, 2019	SELL	$25.38 - $34.89 $6.42 Million - $8.83 Million	-252,979 Reduced 11.18%	2,009,829 $65.9 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $655,667 - $1.02 Million	36,939 Added 1.66%	2,262,808 $62.4 Million
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $1.48 Million - $2.69 Million	130,422 Added 6.22%	2,225,869 $45.9 Million
Q4 2018 Feb 15, 2019	BUY	$12.32 - $24.38 $1.35 Million - $2.68 Million	109,869 Added 5.53%	2,095,447 $29.3 Million
Q3 2018 Nov 15, 2018	BUY	$18.82 - $28.96 $5.09 Million - $7.84 Million	270,692 Added 15.78%	1,985,578 $47.5 Million
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $1.24 Million - $2.82 Million	141,278 Added 8.98%	1,714,886 $32.3 Million
Q1 2018 May 11, 2018	BUY	$9.0 - $11.95 $715,104 - $949,499	79,456 Added 5.32%	1,573,608 $14.6 Million
Q4 2017 Feb 15, 2018	BUY	$8.99 - $14.31 $1.41 Million - $2.25 Million	157,159 Added 11.75%	1,494,152 $13.4 Million
Q3 2017 Nov 08, 2017	BUY	$8.02 - $13.33 $10.7 Million - $17.8 Million	1,336,993	1,336,993 $17.2 Million

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Natera, Inc. Transaction History